Pharma Focus Asia

The Neuropsychology of Psychopharmacology

The Neuropsychology of Psychopharmacology

Pages: 504

Publisher: Springer Publishing Company

Year of Publication: 2017

Author(s) : Chad A. Noggle, Raymond S. Dean, Simon Crowe, Stephen Soltys and Stephen Robinson

Book Description:

The use of pharmacological interventions to treat the symptoms of psychological disorders is readily becoming the first-line option for clinicians and their clients. Although most neurological and psychiatric professionals are well versed in medicinal agents, many remain uninformed about current pharmacologic practices that may have positive or negative neuropsychological impact. This text serves as an up-to-date reference for clinicians and researchers, covering current practices and advances in pharmacological interventions for psychiatric and neurological presentations and the pharmacologic mechanisms that influence the actions of the central nervous system and behavioral outcomes. This journal explores key topics like foundational principles and concepts relevant to pharmacology, including: agent selection, addressing symptoms, physiological factors, and treatment guidelines, pharmacological principles of pharmacokinetics and drug uptake, comparison of positive and negative outcomes of drug interactions as well as specific practices in pharmacology, including comparative efficacy of agents as well as differential selection based on symptom constellation.

Ref : http://www.springerpub.com/the-neuropsychology-of-psychopharmacology.html

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024